Global Carcinoembryonic Antigen Market – Overview

Carcinoembryonic Antigen or CEA is a kind of glycoprotein produced by cells of the gastrointestinal tract during foetal development which is involved in cell adhesion. Its level is low in healthy adults. However, high levels of CEA are marked in cancerous conditions. The normal range for CEA in an adult who is non-smoker is estimated to be about <2.5 ng/ml. Similarly for smokers the level of CEA ranges about <5.0 ng/ml. Therefore, on the basis of CEA profiling a number of cancers including colorectal, pancreatic, breast, lung, and others can be easily diagnosed. It is reported that the CEA based diagnostic assays are mostly used for the detection of colorectal cancer.

Factors such as increasing awareness, technological advancements in the medical sector and proteomics, increasing prevalence of colorectal cancer,  and lifestyle changes involving the consumption of junk foods, alcohol, and others provides favourable backgrounds for the market growth.

Get Request Free Sample @ https://www.marketresearchfuture.com/sample_request/772

However, side effects related to the CEA test including unreasonable bleeding followed by blacking out, hematoma, risk of infection, erroneous readings and low healthcare expenditures in middle and low income countries is estimated to restrain the market growth during the forecast period.

The global carcinoembryonic antigen market is expected to grow 6.7% during the forecast period.

Global Carcinoembryonic Antigen Market - competitive Analysis

In 2017, Aviva Systems Corporation (ASB), a protein solutions and application provider acquired GenWay Biotech, Inc. GenWay Biotech founded in 1998 has a multi-functional technology platform specialized in proteins and antibody solutions. GenWay’s core competencies enable the company to carry out bioinformatic analyses of protein targets, produce high-quality protein antigens and ligands. The GenWay, Inc.’s CEA ELISA Kit is intended for the quantitative measurement of CEA in human serum.

Biocare Medical is a privately held company which is leading supplier of automated immunohistochemistry instrumentation, antibodies and a range of IHC products. Biocare Medical sales CARCINOEMBRYONIC ANTIGEN (CEA {P} commercially. Carcinoembryonic Antigen (CEA {M}) [COL-1] is a mouse monoclonal antibody used to qualitatively detect CEA antigen by Immuno histo chemistry in formalin-fixed paraffin-embedded (FFPE) human tissues.

Lee biosolutions is a leading manufacturer of native enzymes, proteins, antibodies recombinant proteins and biological. It manufactures CEA antigens available in lyophilised form from human metastatic liver cells. The antigens are highly pure ensuring no cross contamination with other cancer antigens.

Global Carcinoembryonic Antigen Market - Regional Analysis

The Americas account for the largest share in the carcinoembryogenic antigen market. The Americas mainly include countries like the U.S. and Canada. Increasing prevalence of cancer and high healthcare expenditures within the region will boost the market growth over the assessment period.

Europe is the second highest revenue generating region in the global carcinoembryogenic antigen market. Increasing prevalence of cancer, fast adoption of new technologies and presence of developed countries like Germany and U.K within the region will boost the market growth during the forecasted period.

On account of the developing medical infrastructure, rising healthcare expenditure, and increasing government initiatives, Asia Pacific region is expected to grow the fastest.

The Middle East & Africa is expected to grow slower than the global average. The Middle Eastern countries, for instance, UAE and Saudi Arabia dominates the market due to high income and the government support to improve public health. 

Taste the market data and market information presented through more than 50 market data tables and figures spread over 80 pages of the project report. Avail the in-depth table of content (TOC) & market synopsis on “Global Carcinoembryogenic Antigen Market” Research Report – Forecast till 2023.

Market Players

Some of key players profiled in the report are Lee BioSolutions, F. Hoffmann-La Roche Ltd, Quest Diagnostics Incorporated., Correlogic Systems, Inc, Genway Biotech, Inc., Abbott., RayBiotech, Inc., Abcam plc., Biocare Medical, LLC, and Biocare Medical, LLC.

TABLE OF CONTENTS

1. REPORT PROLOGUE
2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Primary Research

3.3. Secondary Research

3.4. Market Size Estimation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Porter’s Five Forces Analysis

5.1.1. Bargaining Power of Suppliers

5.1.2. Bargaining Power of Buyers

5.1.3. Threat of New Entrants

5.1.4. Threat of Substitutes

5.1.5. Intensity of Rivalry

5.2. Value Chain Analysis

5.2.1. R&D and Designing

5.2.2. Manufacturing

5.2.3. Distribution & Sales

5.2.4. Post Sales Services

Browse Complete Report With Consider Covid19 Impact @ https://www.marketresearchfuture.com/reports/carcinoembryonic-antigen-market-772

Related reports link:-

Ophthalmic Lasers Market
ADME Toxicology Testing Market
Flexible & Semi-rigid Ureteroscopy Market

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

https://marketreports4u.blogspot.com/